0000000000926730

AUTHOR

Angelica Naldini

showing 2 related works from this author

Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies: A Multicentric Study

2018

Objectives This retrospective, multicentric study investigates quality-of-life issues and emotional distress in gynecological cancer survivors submitted to pelvic exenteration (PE). Methods The Global Health Status scale of European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30; the EORTC QLQ-CX24 (CX24), and EORTC QLQ-OV28 questionnaires were administered at least 12 months from surgery only in women with no evidence of further recurrence after PE. Statistical analysis was performed by the analysis of variance (for repeated measures. Results Ninety-six subjects affected by gynecological malignancies receiving PE were enrolled in the s…

Adultmedicine.medical_specialtyConstipationGenital Neoplasms Femalemedicine.medical_treatmentHealth StatusUrinary Diversion03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesmedicineBody ImageHumansAgedRetrospective StudiesGynecology030219 obstetrics & reproductive medicinePelvic exenterationbusiness.industryHazard ratioColostomyRepeated measures designObstetrics and GynecologyRetrospective cohort studyQuality of life Pelvic exenteration Gynecological cancerVulvar cancerMiddle Agedmedicine.diseasePelvic ExenterationOncology030220 oncology & carcinogenesisGynecological cancerQuality of LifeFemalemedicine.symptombusiness
researchProduct

Peritoneal carcinosis of ovarian origin

2010

Epithelial ovarian cancer (EOC) is the second most common genital malignancy in women and is the most lethal gynecological malignancy, with an estimated five-year survival rate of 39%. Despite efforts to develop an effective ovarian cancer screening method, 60% of patients still present with advanced disease. Comprehensive management using surgical cytoreduction to decrease the tumor load to a minimum, and intraperitoneal chemotherapy to eliminate microscopic disease on peritoneal surface, has the potential to greatly improve quality of life and to have an impact on survival in ovarian cancer patients. Despite achieving clinical remission after completion of initial treatment, most patients…

Oncologymedicine.medical_specialtyendocrine system diseasesbusiness.industryPeritoneal carcinosisGastroenterologyDrug resistancemedicine.diseaseMalignancySettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsSurgeryCytoreductionOvarian cancer Intraperitoneal hyperthermic chemotherapyOncologyQuality of lifePeritoneal carcinosiInternal medicinemedicineSex organTopic HighlightOvarian cancerbusinessSurvival rateTumor LoadWorld Journal of Gastrointestinal Oncology
researchProduct